- Report
- December 2023
- 160 Pages
Global
From €2423EUR$2,500USD£2,075GBP
- Report
- January 2024
- 112 Pages
Global
From €3500EUR$3,869USD£3,103GBP
- Report
- July 2020
Japan, United States, ... Japan, United States, Europe, Global
From €727EUR$750USD£623GBP
- Report
- July 2020
Japan, United States, ... Japan, United States, Europe, Global
From €727EUR$750USD£623GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €921EUR$950USD£789GBP
From €727EUR$750USD£623GBP
From €727EUR$750USD£623GBP
- Report
- February 2023
Global
From €824EUR$850USD£706GBP
- Report
- February 2023
Global
From €824EUR$850USD£706GBP
- Report
- March 2022
Global
From €4700EUR$4,850USD£4,026GBP
- Report
- March 2022
Global
From €4700EUR$4,850USD£4,026GBP
- Report
- March 2022
Global
From €4700EUR$4,850USD£4,026GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €921EUR$950USD£789GBP
The Bilirubin Test is a type of In Vitro Diagnostics (IVD) used to measure the amount of bilirubin in a patient's blood. Bilirubin is a yellow pigment produced by the breakdown of red blood cells. High levels of bilirubin can indicate liver or gallbladder disease, or other conditions such as anemia. The Bilirubin Test market is composed of a variety of products, including reagents, instruments, and software. Reagents are used to measure bilirubin levels in a patient's blood, while instruments are used to analyze the results. Software is used to store and analyze the data.
The Bilirubin Test market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Beckman Coulter. Show Less Read more